Galenica
Galenica AG, headquartered in Switzerland (CH), is a leading player in the healthcare and pharmaceutical industry, primarily focusing on the distribution and retail of pharmaceuticals and healthcare products. Founded in 1927, Galenica has established itself as a trusted name, with significant operations across Switzerland and a growing presence in Europe. The company excels in providing a comprehensive range of services, including logistics, pharmacy management, and health-related solutions, which are distinguished by their commitment to quality and innovation. Galenica's unique approach integrates digital solutions with traditional pharmacy services, enhancing customer experience and operational efficiency. With a strong market position, Galenica has achieved notable milestones, including strategic partnerships and expansions that reinforce its reputation as a reliable healthcare provider. The company's dedication to improving patient outcomes and its robust portfolio of products and services make it a key player in the evolving healthcare landscape.
DitchCarbon Score
How does Galenica's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Galenica's score of 30 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Galenica's reported carbon emissions
In 2023, Galenica reported total carbon emissions of approximately 12,669,000 kg CO2e, with emissions distributed across various scopes: 6,875,000 kg CO2e from Scope 1, 2,283,000 kg CO2e from Scope 2, and 3,512,000 kg CO2e from Scope 3. This marks an increase from 2022, where total emissions were about 10,052,000 kg CO2e. Over the years, Galenica's emissions have fluctuated, with total emissions recorded at 11,828,000 kg CO2e in 2021 and 10,207,000 kg CO2e in 2020. The company has disclosed emissions data across all three scopes, indicating a comprehensive approach to tracking its carbon footprint. Despite the lack of specific reduction targets or climate pledges, Galenica's commitment to sustainability is evident through its ongoing emissions reporting and transparency. The company continues to monitor its carbon emissions, aiming to improve its environmental impact in the pharmaceutical and healthcare sectors.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 3,008,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,771,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 3,040,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Galenica is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
